Standout Papers

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylit... 2003 2026 2010 2018 571
  1. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial (2003)
    John C. Davis, Désirée van der Heijde et al. Arthritis & Rheumatism
  2. Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial (2008)
    Robert D. Inman, John C. Davis et al. Arthritis & Rheumatism

Immediate Impact

3 by Nobel laureates 13 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

The JAK-STAT pathway at 30: Much learned, much more to do
2022 Standout
A guide to antigen processing and presentation
2022 Standout
6 intermediate papers

Works of Robert D. Inman being referenced

Immunodominance: A pivotal principle in host response to viral infections
2012
Differential Role of Actin, Clathrin, and Dynamin in Fcγ Receptor-mediated Endocytosis and Phagocytosis
2003
and 5 more

Author Peers

Author Last Decade Papers Cites
Robert D. Inman 9056 5772 3363 366 14.1k
Dominique Baeten 9527 8047 3757 322 15.7k
Barry Bresnihan 7141 3964 2233 231 12.6k
Larry W. Moreland 11918 4650 4910 285 18.4k
H. Zeidler 7765 3499 2495 226 10.5k
Jean Sibilia 6667 4015 2614 457 16.3k
Costantino Pitzalis 4671 6033 1294 332 13.8k
Marjatta Leirisalo‐Repo 6542 2570 2353 293 9.7k
G S Panayi 5265 5026 1427 255 12.2k
William P. Arend 7180 7425 1542 136 21.6k
Eloísa Bonfá 5567 3543 1132 417 9.9k

All Works

Loading papers...

Rankless by CCL
2026